I. Introduction
Cardiovascular disease (CVD) is now the most common cause of death worldwide. Today, CVD accounts for approximately30% of deaths worldwide, including nearly 40% in high income countries and about 28% in low and middle-income countries. The global rise in CVD is the result of an unprecedented transformation in the causes of morbidity and mortality during the twenty-first centuries. This shift is driven by industrialization, urbanization, and associated lifestyle changes and is taking place in every part of the world. The metabolic syndrome (syndrome X , insulin resistance syndrome) consists of a constellation of metabolic abnormalities (central obesity, low HDL-C(high-density lipoprotein cholesterol), hyper triglyceridemia, hyperglycemia and hypertension) that confer an increased risk of Cardiovascular Disease(CVD) and Diabetes Mellitus(DM) 1 .These risk factors, when present together, increase the risk of cardiovascular disease substantially, because their combined effects are multiplicative rather than additive . Rates of Type 2 diabetes mellitus, hypertension, and lipid abnormalities are on the rise, trends that are particularly evident in children. If these risk factor trends continue, age-adjusted CVD mortality rates could increase in the coming years. 2 It is estimated that around 20-25 percent of the world's adult population have the metabolic syndrome and they are twice as likely to die from and three times as likely to have a heart attack or stroke compared with people without the syndrome. In addition, people with metabolic syndrome have a five-fold greater risk of developing type 2 diabetes. The clustering of cardiovascular disease (CVD) risk factors that typifies the metabolic syndrome is now considered to be the driving force for a new CVD epidemic.The pathophysiology seems to be largely attributable to insulin resistance with excessive flux of fatty acids implicated. A pro-inflammatory state probably contributes to the syndrome. The metabolic syndrome has a correlation with the variations in genetic susceptibility, nutritional regimen, physical exercise, chronological age and gender which play direct role in the incidence of metabolic syndrome and its side effects. Early intervention of the individual components of the metabolic syndrome with intensive lifestyle changes in the form of diet changes, exercise and pharmacotherapy can prevent the development of cardiovascular disease like myocardial infarction. Community based programmes to promote healthy living are needed to tackle this crisis.This study has been undertaken to assess and analyse the prevalence of metabolic syndrome and its various components in patients with acute Myocardial Infarction and the impact of metabolic syndrome on the prognosis of patients with acute myocardial infarction during hospital stay.
II. Objectives
To study the prevalence of metabolic syndrome in patients with acute myocardial infarction admitted to Rajendra Institute of Medical Sciences , Ranchi. To assess and analyse the prevalence of individual components of metabolic syndrome in patients with acute myocardial infarction admitted to Rajendra Institute of Medical Sciences , Ranchi. To assesss the impact of metabolic syndrome on the prognosis of patients with acute myocardial infarction during one week of in-hospital stay.
III. Materials and Methods
In Out of 132 patients of acute myocardial infarction, 65 patients were found to have metabolic syndrome as per modified NCEP-ATP III criteria. Prevalence of metabolic syndrome in acute MI in our study was found to be 49.2%.
IV. Results
The most common symptom in patients of myocardial infarction with metabolic syndrome and without metabolic syndrome was chest pain followed by sweating, shortness of breath , palpitation and vomiting. proportion of patients with syncope was significantly higher in patients of metabolic syndrome than that in patients without metabolic syndrome . The risk of metabolic syndrome was 8.32 times more among the patients with past history of Diabetes Mellitus as compared to the patients without past history of Diabetes Mellitus [OR-8.32] and the risk was significant .past history of hypertension (HTN)-(77.8%) was significantly higher than those without metabolic syndrome (29.5%) . The risk of metabolic syndrome was 2.79 times more among the patients with family history of IHD as compared to the patients without family history of IHD [OR-2.79]. there was no significant association between chronic smoking and alcohol consumption and metabolic syndrome FBS >100 mg/dl and metabolic syndrome:
The risk of metabolic syndrome was 13.62 times more among the patients with FBS≥100 mg/dl as compared to the patients with FBS<100 mg/dl [OR-13.62 ( 
WC and metabolic syndrome in females
The risk of metabolic syndrome was 12.14 times more among the females with WC>80 cm as compared to the females with WC<80cm [OR-12.14(2.09, 70.22); p=0.007] and the risk was significant.
Case mortality and metabolic syndrome :
Test of proportion showed that among the patients with metabolic syndrome case mortality was significantly higher (27.7%) (p<0.01).
Prevalence Of Individual Components Of Metabolic Syndrome In Patients Of Acute Mi With Metabolic
Syndrome:
V. Discussion
This was a hospital-based, cross-sectional observational study. 132 cases of Acute Myocardial Infarction (AMI) admitted to the ICCU& Cardiology wards of RIMS , Ranchi. during the period between 1 st Sept, 2015 to Oct 31 st , 2016 were studied. All cases were included keeping in mind the inclusion and exclusion criteria. Prevalence of metabolic syndrome (as defined by revised NCEP ATP III criteria ) in Acute MI was 49.2 % in our study, which is comparable to the prevalence rates of 46 %, 49 %,49.8 % and 47.14 % found in studies conducted by Zeller et al., Prasad SB, Babic Z et al and Sarkar S respectively suggesting that metabolic syndrome, is very common among patients with coronary artery disease /myocardial infarction, because almost 1 in 2 patients had metabolic syndrome and that it is associated with advanced vascular damage. Our study confirms the high prevalence of metabolic syndrome in patients with MI,suggesting that the metabolic syndrome has clinical utility in identifying patients at increased risk of AMI .The mean age of acute MI with metabolic syndrome in our study was almost the same(59.73 yrs) compared to the mean age found in studies conducted by Levantesi G (59.0 yrs) and Pandey S et al. (60.69 yrs). In the present study, past history of diabetes mellitus , hypertension and family history of IHD was more in patients with Metabolic syndrome compared to patients without Metabolic syndrome, which was statistically significant. However, there was no statistically significant difference in the association between smoking, alcohol consumption and metabolic syndrome.Our study showed a higher prevalence of known cases of diabetes mellitus and family history of IHD among patients having metabolic syndrome, compared to other studies. In our study, the most prevalent component of metabolic syndrome was low HDL-C (90.8%) followed by increased fasting blood sugar (86. 
VI. Conclusion
There is high prevalence of metabolic syndrome and its individual components in patients of acute myocardial infarction, suggesting that the metabolic syndrome has clinical utility in identifying patients at increased risk of Acute MI. The presence of metabolic syndrome in patients of acute myocardial infarction worsens the prognosis of such patients. Complications like heart failure, ventricular tachycardia/ventricular fibrillation, re-infarction and mortality were significantly higher in patients having metabolic syndrome.Low HDL-C was the most prevalent component among patients having metabolic syndrome, followed by increased fasting blood sugar levels. To conclude, our findings clinch the importance of the metabolic syndrome as a significant risk factor for cardiovascular disease, particularly myocardial infarction. This reaffirms the need to develop stringent strategies for controlling this syndrome and also its individual components. Hence, prevention, detection and optimal management of metabolic syndrome is likely to reduce cardiovascular risk and early management will save the precious human lives.
